9926 — Akeso Share Price
Last trade - 00:00- HK$38.01bn
- HK$38.47bn
- CNY4.53bn
- 39
- 31
- 89
- 54
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.49 | ||
| Price to Tang. Book | 7.5 | ||
| Price to Free Cashflow | 14.24 | ||
| Price to Sales | 7.76 | ||
| EV to EBITDA | 16.04 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 25.44% | ||
| Return on Equity | 55.36% | ||
| Operating Margin | 44.84% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 70.88 | n/a | 225.63 | 837.66 | 4,526.25 | 2,693.26 | 4,278.43 | 337.43% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Akeso Inc is an investment holding company mainly engaged in the research and development of biological products. The Company is dedicated to addressing global unmet medical needs in oncology, immunology and other therapeutic areas. The Company's main products include AK104, AK105, AK112 and AK109. The Company conducts its businesses within the China market and to overseas markets.
Directors
- Yu Xia CHM (54)
- Xiaojie Xi CFO (45)
- Baiyong Li SVP (52)
- Zhongmin Wang SVP (52)
- Yu Xia SVP (50)
- Xiaoping Jin VPR (44)
- Peng Zhang VPR (44)
- Pui Chun Suen SEC (43)
- Ronggang Xie NED (36)
- Yi Zhou NED (40)
- Bo Tan NID (47)
- Yan Xu NID (57)
- Junwen Zeng NID (59)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 30th, 2019
- Public Since
- April 24th, 2020
- No. of Employees
- 2,778
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 865,857,176
- Address
- No.6 Shennong Road, Zhongshan, 528437
- Web
- https://www.akesobio.com/
- Phone
- +86 76089873998
- Auditors
- Ernst & Young
Upcoming Events for 9926
Similar to 9926
Abbisko Cayman
Stock Exchange of Hong Kong Limited
Alphamab Oncology
Stock Exchange of Hong Kong Limited
Antengene
Stock Exchange of Hong Kong Limited
Ascentage Pharma International
Stock Exchange of Hong Kong Limited
Beigene
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:01 UTC, shares in Akeso are trading at HK$43.90. This share price information is delayed by 15 minutes.
Shares in Akeso last closed at HK$43.90 and the price had moved by +1.39% over the past 365 days. In terms of relative price strength the Akeso share price has outperformed the FTSE Developed Asia Pacific Index by +5.82% over the past year.
The overall consensus recommendation for Akeso is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Akeso does not currently pay a dividend.
Akeso does not currently pay a dividend.
Akeso does not currently pay a dividend.
To buy shares in Akeso you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$43.90, shares in Akeso had a market capitalisation of HK$38.01bn.
Here are the trading details for Akeso:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 9926
Based on an overall assessment of its quality, value and momentum Akeso is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Akeso is HK$60.29. That is 37.33% above the last closing price of HK$43.90.
Analysts covering Akeso currently have a consensus Earnings Per Share (EPS) forecast of -CNY0.40 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Akeso. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +6.62%.
As of the last closing price of HK$43.90, shares in Akeso were trading +4.92% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Akeso PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$43.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Akeso's management team is headed by:
- Yu Xia - CHM
- Xiaojie Xi - CFO
- Baiyong Li - SVP
- Zhongmin Wang - SVP
- Yu Xia - SVP
- Xiaoping Jin - VPR
- Peng Zhang - VPR
- Pui Chun Suen - SEC
- Ronggang Xie - NED
- Yi Zhou - NED
- Bo Tan - NID
- Yan Xu - NID
- Junwen Zeng - NID